PBA
Paradigm Biocapital Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Buy |
878,323
+250,900
| +40% | +$11.8M | 1.77% | 17 |
|
|
2025
Q1 | $24.5M | Sell |
627,423
-1,144,788
| -65% | -$44.7M | 1.12% | 22 |
|
|
2024
Q4 | $96M | Buy |
1,772,211
+840,731
| +90% | +$45.5M | 3.34% | 11 |
|
|
2024
Q3 | $47M | Buy |
+931,480
| New | +$47M | 1.59% | 19 |
|
|
2023
Q3 | – | Sell |
-369,615
| Closed | -$18.9M | – | 32 |
|
|
2023
Q2 | $18.9M | Buy |
+369,615
| New | +$18.9M | 1.46% | 27 |
|